• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病患者的低钾血症。

Hypokalemia in Diabetes Mellitus Setting.

机构信息

Department of Medicine, Nephrology Division, Federal University of São Paulo, São Paulo 04038-901, Brazil.

Instituto Israelita de Ensino e Pesquisa, Albert Einstein Hospital, São Paulo, São Paulo 05652-900, Brazil.

出版信息

Medicina (Kaunas). 2022 Mar 16;58(3):431. doi: 10.3390/medicina58030431.

DOI:10.3390/medicina58030431
PMID:35334607
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8954285/
Abstract

Diabetes mellitus is a public health problem that affects millions of people worldwide regardless of age, sex, and ethnicity. Electrolyte disturbances may occur as a consequence of disease progression or its treatment, in particular potassium disorders. The prevalence of hypokalemia in diabetic individuals over 55 years of age is up to 1.2%. In patients with acute complications of diabetes, such as diabetic ketoacidosis, this prevalence is even higher. Potassium disorders, either hypokalemia or hyperkalemia, have been associated with increased all-cause mortality in diabetic individuals, especially in those with associated comorbidities, such as heart failure and chronic kidney disease. In this article, we discuss the main conditions for the onset of hypokalemia in diabetic individuals, briefly review the pathophysiology of acute complications of diabetes mellitus and their association with hypokalemia, the main signs, symptoms, and laboratory parameters for the diagnosis of hypokalemia, and the management of one of the most common electrolyte disturbances in clinical practice.

摘要

糖尿病是一个全球性的公共卫生问题,影响着数以百万计的人,无论其年龄、性别和种族如何。电解质紊乱可能是疾病进展或其治疗的结果,特别是钾紊乱。55 岁以上糖尿病患者低钾血症的患病率高达 1.2%。在患有糖尿病急性并发症的患者中,如糖尿病酮症酸中毒,这种患病率甚至更高。钾紊乱,无论是低钾血症还是高钾血症,都与糖尿病患者的全因死亡率增加有关,特别是在伴有心力衰竭和慢性肾病等合并症的患者中。在本文中,我们讨论了糖尿病患者低钾血症发生的主要情况,简要回顾了糖尿病急性并发症的病理生理学及其与低钾血症的关系,低钾血症的诊断的主要体征、症状和实验室参数,以及在临床实践中最常见的电解质紊乱之一的处理方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16f0/8954285/90ad3e5188a0/medicina-58-00431-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16f0/8954285/b99ded4690ea/medicina-58-00431-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16f0/8954285/e23cff08b186/medicina-58-00431-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16f0/8954285/90ad3e5188a0/medicina-58-00431-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16f0/8954285/b99ded4690ea/medicina-58-00431-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16f0/8954285/e23cff08b186/medicina-58-00431-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16f0/8954285/90ad3e5188a0/medicina-58-00431-g003.jpg

相似文献

1
Hypokalemia in Diabetes Mellitus Setting.糖尿病患者的低钾血症。
Medicina (Kaunas). 2022 Mar 16;58(3):431. doi: 10.3390/medicina58030431.
2
Profound hypokalemia associated with severe diabetic ketoacidosis.与严重糖尿病酮症酸中毒相关的严重低钾血症
Pediatr Diabetes. 2016 Feb;17(1):61-5. doi: 10.1111/pedi.12246. Epub 2014 Nov 27.
3
Predictors of Hyperkalemia and Hypokalemia in Individuals with Diabetes: a Classification and Regression Tree Analysis.糖尿病患者高钾血症和低钾血症的预测因素:一项分类与回归树分析
J Gen Intern Med. 2020 Aug;35(8):2321-2328. doi: 10.1007/s11606-020-05799-x. Epub 2020 Apr 16.
4
Hyperkalemia in Diabetes Mellitus Setting.糖尿病环境下的高钾血症
Diseases. 2022 Mar 28;10(2):20. doi: 10.3390/diseases10020020.
5
[Disorders of potassium metabolism in diabetic acidoketosis].糖尿病性酮症酸中毒时的钾代谢紊乱
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna. 1974 Jul-Aug;26(7):829-41.
6
Profound hypokalemia in diabetic ketoacidosis: a therapeutic challenge.糖尿病酮症酸中毒中的严重低钾血症:一项治疗挑战。
Endocr Pract. 2005 Sep-Oct;11(5):331-4. doi: 10.4158/EP.11.5.331.
7
Prevalence of hypokalemia in ED patients with diabetic ketoacidosis.ED 患者糖尿病酮症酸中毒中低钾血症的患病率。
Am J Emerg Med. 2012 Mar;30(3):481-4. doi: 10.1016/j.ajem.2011.01.002. Epub 2011 Feb 11.
8
Hyperkalemia and Hypokalemia in CKD: Prevalence, Risk Factors, and Clinical Outcomes.慢性肾脏病中的高钾血症和低钾血症:患病率、危险因素及临床结局
Adv Chronic Kidney Dis. 2017 Sep;24(5):315-318. doi: 10.1053/j.ackd.2017.06.004.
9
Association between hypo- and hyperkalemia and outcome in acute heart failure patients: the role of medications.低钾血症和高钾血症与急性心力衰竭患者预后的关系:药物的作用。
Clin Res Cardiol. 2018 Mar;107(3):214-221. doi: 10.1007/s00392-017-1173-3. Epub 2017 Oct 28.
10
Clinical hypokalemia and hyperkalemia at the bedside.床旁的临床低钾血症和高钾血症。
J Nephrol. 2010 Nov-Dec;23 Suppl 16:S105-11.

引用本文的文献

1
Impact of multifactorial interventions with medication and lifestyle optimization on patients with type 2 diabetes: A randomised controlled trial.药物治疗与生活方式优化的多因素干预对2型糖尿病患者的影响:一项随机对照试验。
PLoS One. 2025 Jul 9;20(7):e0327211. doi: 10.1371/journal.pone.0327211. eCollection 2025.
2
Control of type 2 diabetes in patients with cancer and chronic pro-inflammatory cytokines during the COVID-19 pandemic.2019冠状病毒病大流行期间癌症患者和慢性促炎细胞因子患者的2型糖尿病控制
J Med Life. 2025 May;18(5):428-439. doi: 10.25122/jml-2025-0061.
3
Genetic association of long non-coding RNA ANRIL polymorphism with the risk of type 2 diabetes mellitus in the Chinese Han population.

本文引用的文献

1
Safety and Efficacy of Adding Dapagliflozin to Furosemide in Type 2 Diabetic Patients With Decompensated Heart Failure and Reduced Ejection Fraction.在射血分数降低的失代偿性心力衰竭2型糖尿病患者中,加用达格列净至呋塞米的安全性和有效性。
Front Cardiovasc Med. 2020 Dec 7;7:602251. doi: 10.3389/fcvm.2020.602251. eCollection 2020.
2
Efficacy and safety of dapagliflozin in acute heart failure: Rationale and design of the DICTATE-AHF trial.达格列净治疗急性心力衰竭的疗效和安全性:DICTATE-AHF 试验的原理和设计。
Am Heart J. 2021 Feb;232:116-124. doi: 10.1016/j.ahj.2020.10.071. Epub 2020 Nov 2.
3
Real-World Epidemiology of Potassium Derangements Among Chronic Cardiovascular, Metabolic and Renal Conditions: A Population-Based Analysis.
中国汉族人群中长链非编码RNA ANRIL基因多态性与2型糖尿病风险的遗传关联
Diabetol Metab Syndr. 2025 Mar 28;17(1):108. doi: 10.1186/s13098-025-01670-3.
4
Electrolyte Imbalances and Metabolic Emergencies in Obesity: Mechanisms and Clinical Implications.肥胖中的电解质失衡与代谢急症:机制与临床意义
Diseases. 2025 Feb 24;13(3):69. doi: 10.3390/diseases13030069.
5
Effectiveness of ertugliflozin during Ramadan fasting in patients with type 2 diabetes mellitus: a real-world study (ErtuRamadan study).恩格列净在斋月禁食期间对2型糖尿病患者的有效性:一项真实世界研究(恩格列净斋月研究)
Front Endocrinol (Lausanne). 2025 Feb 11;16:1542946. doi: 10.3389/fendo.2025.1542946. eCollection 2025.
6
Nutritional risk and HbA1c as critical risk factors and predictors of opportunistic infections in HIV-DM comorbid patients: a retrospective cross-sectional study.营养风险和糖化血红蛋白作为HIV-DM合并症患者机会性感染的关键风险因素及预测指标:一项回顾性横断面研究
Front Endocrinol (Lausanne). 2025 Jan 10;15:1527936. doi: 10.3389/fendo.2024.1527936. eCollection 2024.
7
Delving into the complexities of the interplay between acute kidney injury and diabetic kidney disease: A focus on glycemic control and outcomes.深入探讨急性肾损伤与糖尿病肾病之间相互作用的复杂性:聚焦血糖控制与预后。
J Bras Nefrol. 2025 Jan-Mar;47(1):e20240074. doi: 10.1590/2175-8239-JBN-2024-0074en.
8
Evaluation of potential human health risks associated with Li and their relationship with Na, K, Mg, and Ca in Romania's nationwide drinking water.评估罗马尼亚全国饮用水中 Li 与 Na、K、Mg 和 Ca 之间的关系及其对人体健康的潜在风险。
Front Public Health. 2024 Sep 23;12:1456640. doi: 10.3389/fpubh.2024.1456640. eCollection 2024.
9
The influence of salt reduction with encapsulated oleoresins on the quality of mayonnaise, mustard, and ketchup.用微胶囊化油树脂减少盐分对蛋黄酱、芥末酱和番茄酱品质的影响。
Front Nutr. 2024 Sep 19;11:1456319. doi: 10.3389/fnut.2024.1456319. eCollection 2024.
10
Prevalence and impact of diabetes and prediabetes on presentation and complications of primary hyperaldosteronism at diagnosis.糖尿病和糖尿病前期在原发性醛固酮增多症诊断时的表现及并发症中的患病率和影响。
World J Clin Cases. 2024 Jun 26;12(18):3332-3339. doi: 10.12998/wjcc.v12.i18.3332.
慢性心血管、代谢和肾脏疾病中钾紊乱的真实世界流行病学:一项基于人群的分析。
Clin Epidemiol. 2020 Sep 11;12:941-952. doi: 10.2147/CLEP.S253745. eCollection 2020.
4
Effects of DPP-4 Inhibitor Linagliptin Versus Sulfonylurea Glimepiride as Add-on to Metformin on Renal Physiology in Overweight Patients With Type 2 Diabetes (RENALIS): A Randomized, Double-Blind Trial.二肽基肽酶-4 抑制剂利拉利汀对比磺酰脲类格列美脲作为二甲双胍的附加治疗在超重 2 型糖尿病患者中对肾脏生理的影响(RENALIS):一项随机、双盲试验。
Diabetes Care. 2020 Nov;43(11):2889-2893. doi: 10.2337/dc20-0902. Epub 2020 Sep 8.
5
Type 2 diabetes mellitus caused by Gitelman syndrome-related hypokalemia: A case report.吉特曼综合征相关低钾血症所致2型糖尿病:一例报告
Medicine (Baltimore). 2020 Jul 17;99(29):e21123. doi: 10.1097/MD.0000000000021123.
6
Acute Metabolic Emergencies in Diabetes: DKA, HHS and EDKA.糖尿病的急性代谢危象:DKA、HHS 和 EDKA。
Adv Exp Med Biol. 2021;1307:85-114. doi: 10.1007/5584_2020_545.
7
Empagliflozin in Heart Failure: Diuretic and Cardiorenal Effects.恩格列净在心力衰竭中的应用:利尿剂和心脏肾脏作用。
Circulation. 2020 Sep 15;142(11):1028-1039. doi: 10.1161/CIRCULATIONAHA.120.045691. Epub 2020 May 15.
8
Low serum potassium levels and diabetes - An unfavorable combination in patients with heart failure and preserved ejection fraction.低血钾水平与糖尿病——射血分数保留的心力衰竭患者中的不良组合。
Int J Cardiol. 2020 Oct 15;317:121-127. doi: 10.1016/j.ijcard.2020.04.029. Epub 2020 May 5.
9
Determining the Prevalence of Primary Aldosteronism in Patients With New-Onset Type 2 Diabetes and Hypertension.确定新发 2 型糖尿病伴高血压患者中原发性醛固酮增多症的患病率。
J Clin Endocrinol Metab. 2020 Apr 1;105(4). doi: 10.1210/clinem/dgz293.
10
Mortality attributable to diabetes in 20-79 years old adults, 2019 estimates: Results from the International Diabetes Federation Diabetes Atlas, 9 edition.2019 年国际糖尿病联盟糖尿病地图集第 9 版估算:20-79 岁成年人归因于糖尿病的死亡率。
Diabetes Res Clin Pract. 2020 Apr;162:108086. doi: 10.1016/j.diabres.2020.108086. Epub 2020 Feb 15.